CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash	$ 0	$ 1,173,000
Prepaid drug product	474,000	1,074,000
Other current assets	206,000	1,529,000
Total current assets	680,000	3,776,000
Fixed assets
Furniture, fixtures & equipment	1,010,000	1,077,000
Less accumulated depreciation	(1,001,000)	(1,054,000)
Fixed assets, net	9,000	23,000
Right of use operating assets	57,000	84,000
Total Assets	746,000	3,883,000
Current liabilities
Accounts payable	3,479,000	1,274,000
Notes payable	422,000	0
Accrued expenses	3,906,000	1,938,000
Lease liabilities	57,000	83,000
Total current liabilities	7,864,000	3,295,000
Warrant liability	40,000	434,000
Total Liabilities	7,904,000	3,729,000
Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $.001 par value; 200,000 shares authorized; 8,308 and 5,768 shares issued and outstanding, respectively	8,000	6,000
Additional paid in capital	117,784,000	117,649,000
Accumulated deficit	(124,950,000)	(117,501,000)
Total shareholders' (deficit) equity	(7,158,000)	154,000
Total Liabilities & Shareholders' (Deficit) Equity	$ 746,000	$ 3,883,000